Global Chronic Obstructive Pulmonary Disease Drugs Market to grow at a CAGR of 4.85% during 2016-2020

About Chronic Obstructive Pulmonary Disease (COPD)

COPD is a chronic disease condition with a combination of symptoms of both chronic bronchitis and emphysema. Chronic bronchitis results in inflammation in the bronchioles, which results in increased mucus production. The condition is usually associated with a long-term cough with mucus. Emphysema results in the destruction of the walls of the alveoli, resulting in difficulty in breathing.

Technavios analysts forecast the global chronic obstructive pulmonary disease (COPD) drugs market to grow at a CAGR of 4.85% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global chronic obstructive pulmonary disease (COPD) drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used to treat COPD.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/768106

Key vendors
AstraZeneca
Boehringer Ingelheim
GSK
Merck
Novartis
Teva

Other prominent vendors
Ache Laboratorios Farmaceuticos
Almirall
Aquinox Pharmaceuticals
Ario Pharma
Asmacure
Astellas Pharma
BioMarck Pharmaceuticals
Chiesi Farmaceutici
Cytokinetics
F. Hoffmann-La Roche
Gilead Sciences
Innoviva
Invion
MediciNova
Mereo BioPharma
Mylan
Orion Corporation
Palobiofarma
Pearl Therapeutics
Pharmaxis
Prosonix
Pulmagen Therapeutics
RespiVert
SolAeroMed
Sunovion Pharmaceuticals
Theravance Biopharma
Theron Pharmaceuticals
Verona Pharma
Xention
Yungjin Pharm
ZAI Lab

Market driver
Uptake of LABA/LAMA combination therapies
For a full, detailed list, view our report

Market challenge
Negligence toward use of controller medications
For a full, detailed list, view our report

Market trend
Increased adoption of e-cigarettes and smoking cessation products
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.